Cerebral Small Vessels Disease Recruiting Phase 2 Trials for Exenatide (DB01276)

Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral microangiopathy / Small vessel cerebrovascular disease (disorder) / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease

IndicationStatusPhase
DBCOND0072196 (Cerebral Small Vessels Disease)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05356104
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)Treatment